Page last updated: 2024-08-07 16:11:17
D(1B) dopamine receptor
A D(1B) dopamine receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:P21918]
Synonyms
D(5) dopamine receptor;
D1beta dopamine receptor;
Dopamine D5 receptor
Research
Bioassay Publications (46)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 4 (8.70) | 18.7374 |
1990's | 2 (4.35) | 18.2507 |
2000's | 16 (34.78) | 29.6817 |
2010's | 19 (41.30) | 24.3611 |
2020's | 5 (10.87) | 2.80 |
Compounds (49)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
sk&f-38393 | Homo sapiens (human) | Ki | 0.1240 | 1 | 1 |
1h-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- | Homo sapiens (human) | Ki | 0.0027 | 3 | 3 |
amitriptyline | Homo sapiens (human) | Ki | 0.1700 | 1 | 1 |
chlorpromazine | Homo sapiens (human) | Ki | 0.1720 | 1 | 1 |
fluphenazine | Homo sapiens (human) | Ki | 0.0210 | 1 | 1 |
haloperidol | Homo sapiens (human) | IC50 | 0.0050 | 1 | 1 |
haloperidol | Homo sapiens (human) | Ki | 0.1010 | 4 | 4 |
maprotiline | Homo sapiens (human) | Ki | 0.4290 | 1 | 1 |
7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol | Homo sapiens (human) | IC50 | 0.0006 | 2 | 2 |
rbi 257 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
lysergic acid diethylamide | Homo sapiens (human) | Ki | 0.3400 | 1 | 1 |
apomorphine | Homo sapiens (human) | IC50 | 0.0250 | 1 | 1 |
apomorphine | Homo sapiens (human) | Ki | 0.0150 | 1 | 1 |
phenyltoloxamine | Homo sapiens (human) | Ki | 0.4140 | 1 | 1 |
indopan | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
canadine, (s)-isomer | Homo sapiens (human) | Ki | 0.0621 | 1 | 1 |
penfluridol | Homo sapiens (human) | Ki | 0.1250 | 1 | 1 |
butaclamol | Homo sapiens (human) | IC50 | 0.0500 | 1 | 1 |
aripiprazole | Homo sapiens (human) | Ki | 1.6000 | 2 | 2 |
dopamine hydrochloride | Homo sapiens (human) | Ki | 1.0916 | 1 | 2 |
tetrahydropalmatine | Homo sapiens (human) | Ki | 0.3050 | 1 | 1 |
1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)quinolizine | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
gr 127935 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
ecopipam | Homo sapiens (human) | Ki | 0.0020 | 2 | 2 |
pramipexole | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
chloroethylnorapomorphine | Homo sapiens (human) | IC50 | 8.0000 | 1 | 1 |
harmalan | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
corydalmine | Homo sapiens (human) | Ki | 0.2420 | 1 | 1 |
nantenine, (+-)-isomer | Homo sapiens (human) | Ki | 2.3970 | 1 | 1 |
1-methyl-6-methoxy-dihydro-beta-carboline | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
tetrahydrocolumbamine | Homo sapiens (human) | Ki | 0.0095 | 1 | 1 |
chlorprothixene | Homo sapiens (human) | Ki | 0.0090 | 1 | 1 |
sch 23390 | Homo sapiens (human) | IC50 | 0.0011 | 1 | 1 |
sch 23390 | Homo sapiens (human) | Ki | 0.0029 | 4 | 4 |
le 300 | Homo sapiens (human) | Ki | 0.0096 | 6 | 6 |
harmine | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
l 745870 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
sk&f-38393 | Homo sapiens (human) | Ki | 0.1643 | 2 | 3 |
stepholidine | Homo sapiens (human) | Ki | 0.0044 | 1 | 1 |
ngb 2904 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
akuammicine | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
meridianin a | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
cariprazine | Homo sapiens (human) | Ki | 7.9000 | 1 | 1 |
naluzotan | Homo sapiens (human) | Ki | 2.0000 | 1 | 1 |
le 404 | Homo sapiens (human) | Ki | 0.0015 | 5 | 5 |
a 803467 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
sp 203 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
n,n-diallyl-5-methoxytryptamine | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
clozapine | Homo sapiens (human) | Ki | 0.4890 | 2 | 2 |
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
sk&f 81297 | Homo sapiens (human) | EC50 | 0.0014 | 1 | 1 |
ropinirole | Homo sapiens (human) | EC50 | 0.1000 | 1 | 2 |
sk&f 89124 | Homo sapiens (human) | EC50 | 0.0018 | 1 | 2 |
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
chlorpromazine | Homo sapiens (human) | Kb | 1.0000 | 1 | 1 |
haloperidol | Homo sapiens (human) | Kb | 0.0014 | 1 | 1 |
apomorphine | Homo sapiens (human) | ID50 | 0.0390 | 1 | 1 |
clozapine | Homo sapiens (human) | Kb | 10.0000 | 1 | 1 |
New tetrahydroisoquinoline-based DBioorganic & medicinal chemistry letters, , 06-15, Volume: 42, 2021
Identification of C10 nitrogen-containing aporphines with dopamine DBioorganic & medicinal chemistry letters, , 04-15, Volume: 30, Issue:8, 2020
Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.Bioorganic & medicinal chemistry letters, , 08-15, Volume: 30, Issue:16, 2020
Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivity.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 21, Issue:12, 2011
Synopsis of some recent tactical application of bioisosteres in drug design.Journal of medicinal chemistry, , Apr-28, Volume: 54, Issue:8, 2011
Dopamine/serotonin receptor ligands. 9. Oxygen-containing midsized heterocyclic ring systems and nonrigidized analogues. A step toward dopamine D5 receptor selectivity.Journal of medicinal chemistry, , Aug-12, Volume: 47, Issue:17, 2004
Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.Journal of medicinal chemistry, , Jul-05, Volume: 39, Issue:14, 1996
Aporphines. 58. N-(2-chloroethyl) [8,9-2H]norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application.Journal of medicinal chemistry, , Volume: 27, Issue:6, 1984
Synthesis and evaluation of novel alkylpiperazines as potential dopamine antagonists.Journal of medicinal chemistry, , Volume: 24, Issue:6, 1981
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CHBioorganic & medicinal chemistry, , 01-15, Volume: 25, Issue:2, 2017
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.Bioorganic & medicinal chemistry, , Apr-15, Volume: 24, Issue:8, 2016
Return of DJournal of medicinal chemistry, , 09-14, Volume: 60, Issue:17, 2017
Identification of C10 nitrogen-containing aporphines with dopamine DBioorganic & medicinal chemistry letters, , 04-15, Volume: 30, Issue:8, 2020
Synthesis and dopaminergic activity of (R)- and (S)-4-hydroxy-2-(di-n-propylamino)indan.Journal of medicinal chemistry, , Volume: 28, Issue:4, 1985
Aporphines. 58. N-(2-chloroethyl) [8,9-2H]norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application.Journal of medicinal chemistry, , Volume: 27, Issue:6, 1984
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased DJournal of medicinal chemistry, , 06-08, Volume: 60, Issue:11, 2017
β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation.Bioorganic & medicinal chemistry, , 10-15, Volume: 25, Issue:20, 2017
Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonists.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 20, Issue:3, 2010
Remote functionalization of SCH 39166: discovery of potent and selective benzazepine dopamine D1 receptor antagonists.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 20, Issue:3, 2010
Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.Bioorganic & medicinal chemistry letters, , 08-15, Volume: 30, Issue:16, 2020
Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonists.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 20, Issue:3, 2010
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.Journal of medicinal chemistry, , Nov-27, Volume: 51, Issue:22, 2008
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists.Journal of medicinal chemistry, , Apr-07, Volume: 48, Issue:7, 2005
Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities.ACS medicinal chemistry letters, , Apr-10, Volume: 5, Issue:4, 2014
Dopamine/serotonin receptor ligands. Part 15: Oxygenation of the benz-indolo-azecine LE 300 leads to novel subnanomolar dopamine D1/D5 antagonists.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 17, Issue:5, 2007
Dopamine/serotonin receptor ligands. 12(1): SAR studies on hexahydro-dibenz[d,g]azecines lead to 4-chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecin-3-ol, the first picomolar D5-selective dopamine-receptor antagonist.Journal of medicinal chemistry, , Mar-23, Volume: 49, Issue:6, 2006
Dopamine/serotonin receptor ligands. 13: Homologization of a benzindoloazecine-type dopamine receptor antagonist modulates the affinities for dopamine D(1)-D(5) receptors.Journal of medicinal chemistry, , Oct-19, Volume: 49, Issue:21, 2006
Return of DJournal of medicinal chemistry, , 09-14, Volume: 60, Issue:17, 2017
Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.Bioorganic & medicinal chemistry letters, , 08-15, Volume: 30, Issue:16, 2020
The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 24, Issue:2, 2014
Dibenzazecine scaffold rebuilding--is the flexibility always essential for high dopamine receptor affinities?Bioorganic & medicinal chemistry, , Oct-01, Volume: 17, Issue:19, 2009
Dopamine/serotonin receptor ligands. Part 15: Oxygenation of the benz-indolo-azecine LE 300 leads to novel subnanomolar dopamine D1/D5 antagonists.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 17, Issue:5, 2007
Dopamine/serotonin receptor ligands. 16.(1) Expanding dibenz[d,g]azecines to 11- and 12-membered homologues. Interaction with dopamine D(1)-D(5) receptors.Journal of medicinal chemistry, , Sep-06, Volume: 50, Issue:18, 2007
Dopamine/serotonin receptor ligands. 12(1): SAR studies on hexahydro-dibenz[d,g]azecines lead to 4-chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecin-3-ol, the first picomolar D5-selective dopamine-receptor antagonist.Journal of medicinal chemistry, , Mar-23, Volume: 49, Issue:6, 2006
Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 19, Issue:2, 2009
Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.Journal of medicinal chemistry, , Jul-05, Volume: 39, Issue:14, 1996
Synthesis and evaluation of novel alkylpiperazines as potential dopamine antagonists.Journal of medicinal chemistry, , Volume: 24, Issue:6, 1981
Enables
This protein enables 5 target(s):
Target | Category | Definition |
dopamine neurotransmitter receptor activity, coupled via Gs | molecular function | Combining with the neurotransmitter dopamine and activating adenylate cyclase via coupling to Gs to initiate a change in cell activity. [GOC:mah, ISBN:0953351033, IUPHAR_RECEPTOR:2252, IUPHAR_RECEPTOR:2260] |
dopamine neurotransmitter receptor activity | molecular function | Combining with the neurotransmitter dopamine to initiate a change in cell activity. [GOC:PARL, IUPHAR_GPCR:1282, PMID:21711983] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
dopamine binding | molecular function | Binding to dopamine, a catecholamine neurotransmitter formed by aromatic-L-amino-acid decarboxylase from 3,4-dihydroxy-L-phenylalanine. [ISBN:0198506732] |
G protein-coupled receptor activity | molecular function | Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. [GOC:bf, http://www.iuphar-db.org, Wikipedia:GPCR] |
Located In
This protein is located in 6 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
cilium | cellular component | A specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface and of some cytoplasmic parts. Each cilium is largely bounded by an extrusion of the cytoplasmic (plasma) membrane, and contains a regular longitudinal array of microtubules, anchored to a basal body. [GOC:cilia, GOC:curators, GOC:kmv, GOC:vw, ISBN:0198547684, PMID:16824949, PMID:17009929, PMID:20144998] |
brush border membrane | cellular component | The portion of the plasma membrane surrounding the brush border. [GOC:mah] |
synapse | cellular component | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. [GOC:aruk, ISBN:0198506732, PMID:24619342, PMID:29383328, PMID:31998110] |
ciliary membrane | cellular component | The portion of the plasma membrane surrounding a cilium. [GOC:cilia, GOC:dph, GOC:rph] |
non-motile cilium | cellular component | A cilium which may have a variable array of axonemal microtubules but does not contain molecular motors. [GOC:cilia, GOC:dgh, GOC:kmv, PMID:17009929, PMID:20144998, PMID:22118931] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Involved In
This protein is involved in 25 target(s):
Target | Category | Definition |
synaptic transmission, dopaminergic | biological process | The vesicular release of dopamine. from a presynapse, across a chemical synapse, the subsequent activation of dopamine receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:dos, GOC:dph] |
response to amphetamine | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine. [GOC:dph, GOC:ef] |
regulation of systemic arterial blood pressure by vasopressin | biological process | The regulation of blood pressure mediated by the signaling molecule vasopressin. Vasopressin is produced in the hypothalamus, and affects vasoconstriction, and renal water transport. [GOC:mtg_cardio, ISBN:0721643949] |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | biological process | A process that results in a decrease in the diameter of an artery during the norepinephrine-epinephrine response to decreased blood pressure. [GOC:mtg_cardio, ISBN:0721643949] |
intracellular calcium ion homeostasis | biological process | A homeostatic process involved in the maintenance of a steady state level of calcium ions within a cell. [GOC:ceb, GOC:mah] |
adenylate cyclase-activating G protein-coupled receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of adenylyl cyclase activity which results in an increase in the intracellular concentration of cyclic AMP (cAMP). This pathway is negatively regulated by phosphodiesterase, which cleaves cAMP and terminates the signaling. [GOC:dph, GOC:mah, GOC:signaling, GOC:tb, ISBN:0815316194] |
activation of adenylate cyclase activity | biological process | Any process that initiates the activity of the inactive enzyme adenylate cyclase. [GOC:ai] |
adenylate cyclase-activating dopamine receptor signaling pathway | biological process | An adenylate cyclase-activating G protein-coupled receptor signaling pathway initiated by dopamine binding to its receptor, and ending with the regulation of a downstream cellular process. [GOC:mah, GOC:signaling] |
chemical synaptic transmission | biological process | The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:jl, MeSH:D009435] |
associative learning | biological process | Learning by associating a stimulus (the cause) with a particular outcome (the effect). [ISBN:0582227089] |
transmission of nerve impulse | biological process | The neurological system process in which a signal is transmitted through the nervous system by a combination of action potential propagation and synaptic transmission. [GOC:curators, ISBN:0815316194] |
negative regulation of NAD(P)H oxidase activity | biological process | Any process that stops or reduces the activity of the enzyme NAD(P)H oxidase. [GOC:mah] |
wound healing | biological process | The series of events that restore integrity to a damaged tissue, following an injury. [GOC:bf, PMID:15269788] |
response to cocaine | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant. [GOC:ef, GOC:jl] |
positive regulation of adenylate cyclase activity | biological process | Any process that activates or increases the frequency, rate or extent of adenylate cyclase activity. [GOC:go_curators] |
negative regulation of blood pressure | biological process | Any process in which the force of blood traveling through the circulatory system is decreased. [GOC:go_curators, GOC:mtg_cardio] |
regulation of female receptivity | biological process | Any process that modulates the frequency, rate or extent of the willingness or readiness of a female to receive male advances. [GOC:dph, GOC:go_curators, GOC:tb] |
sensitization | biological process | An increased in a behavioral response to a repeated stimulus. For example, a shock to the tail of the marine snail Aplysia, to which the snail responds by withdrawing its gill, will result in increased gill withdrawal the next time the skin is touched. [ISBN:0582227089] |
phospholipase C-activating dopamine receptor signaling pathway | biological process | A phospholipase C-activating receptor G protein-coupled receptor signaling pathway initiated by dopamine binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:dph, GOC:signaling, GOC:tb, PMID:12675914] |
long-term synaptic depression | biological process | A process that modulates synaptic plasticity such that synapses are changed resulting in the decrease in the rate, or frequency of synaptic transmission at the synapse. [GOC:dgh, GOC:dph] |
cellular response to catecholamine stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] and derivatives formed by substitution. [GOC:BHF, GOC:mah] |
reactive oxygen species metabolic process | biological process | The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers. [GOC:mah] |
positive regulation of MAPK cascade | biological process | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. [GOC:go_curators] |
adenylate cyclase-activating adrenergic receptor signaling pathway | biological process | An adenylate cyclase-activating G protein-coupled receptor signaling pathway initiated by a ligand binding to an adrenergic receptor on the surface of the target cell, and ending with the regulation of a downstream cellular process. [GOC:BHF, GOC:mah, GOC:signaling] |
dopamine receptor signaling pathway | biological process | The series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. [GOC:mah, PMID:21711983] |